[1] Younossi ZM,Koenig AB,Abdelatif D,et al.Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence,incidence,and outcomes. Hepatology,2016,64(1):73-84. [2] 赵泽华,范建高. 2016年美国肝病年会非酒精性脂肪性肝病深度报道. 实用肝脏病杂志,2017,20(1):21-24. [3] Fan JG,Kim SU,Wong VW.New trends on obesity and NAFLD in Asia.J Hepatol,2017,67(4):862-873. [4] 赵文霞,张丽慧. 合理应用中成药治疗非酒精性脂肪性肝病.实用肝脏病杂志,2017,20(2):132-134. [5] 李红山,冯琴,胡义扬,等. 脂联素及其受体在脂肪肝病理机制中的意义及中药干预作用. 中华肝脏病杂志,2009,17(11):826-830. [6] 刘晓琳,范建高. 2017年亚太地区肝病年会非酒精性脂肪性肝病研究报道.实用肝脏病杂志,2017,20(3):Ⅲ. [7] Yoon M,Kim MY.The anti-abgiogeni herbal composition Ob-X from morus alba,melissa officinalis,and artemisia capillaries obesity in genetically obese ob/obmice.Pham Biol,2011,49(6):614-619. [8] Chen X,Krakauer T,Oppenheim JJ,et a1.An injectable multicomponent chinese herbal medicine,is a potent inhibitor of T-cell activation.J Altern Complement Med,2004,10(3):519-526. [9] Liu LL,Gong LK,Wang H,et al.Baicalin protects mouse from concanavalin A-induced liver injury through inhibition of cytokine production and hepatocyte apoptosis.Liver Int,2007,27(4):582-591. [10] 闻淑军. 茵栀黄口服液治疗非酒精性脂肪肝的临床疗效研究. 世界中西医结合杂志,2015,13(11):1212-1214. [11] Kleiner DE,Brunt EM,Natta MV,et al.Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology,2005,41(6):1313-1316. [12] Hutton EK,Hassan ES.Late vs early clamping of the umbilical cord in full-term neonates:systematic review and metaanalysis of controlled trials.J Am Med Asso,2014,297(11):124l-1252. [13] Liang H,Zhang L,Wang H,et al.Inhibitory effect of gardenoside on free fatty acid-induced steatosis in HepG2 hepatocytes.Int J Mol Sci,2015,16(11):27749-27756. [14] Dong Q,Chu F,Wu C,et al Scutellaria baicalensis georgi extract protects against alcohol-induced acute liver injury in mice and affects the mechanism of ER stress. Mol Med Rep,2016,13(4):3052-3062. [15] Wang MY,Srinivasan M,Dasari S.Antioxidant activity of yichun blue honeysuckle (YBHS) berry bounteracts CCl4-induced toxicity in liver injury model of mice. Antioxidants (Basel),2017,6(3):1-11. [16] Zeng J,Wang SJ,Li YM,et al.Yinzhihuang oral liquid in the treatment of neonatal jaundice:a meta-analysis. Pharm Biol,2017,55(1):554-559. [17] Ou QQ,Qian XH,Li DY,et al.Yinzhihuang attenuates ANIT-induced intrahepatic cholestasis in rats through up-regulation of mrp2 and bsep expressions. Pediat Res,2016,79(4):589-595. [18] 李腾,齐利峰,于爱真. 茵栀黄口服液辅助治疗新生儿胆道闭锁21例疗效研究.中国药业,2014,15(16):109-111. [19] Gao Y,Song LX,Jiang MN,et al.Effects of traditional Chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Inflammation,2008,31(2):121-132. [20] Chen SP,Tian LL,Liu FL.Clinical observation of Yinzhihuang oral liquid on prevention of the premature infantile jaundice.Chin J Integrat Med,2009, 15(4):299-302. |